IpY.20

N/A

Report date: 2025/05/21 11:38:36
First In Class

Base Information

Drug NameIpY.20
Drug Alias NameIpY.20
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCyclin-dependent kinase inhibitor 1B inhibitors
TargetsCyclin-dependent kinase inhibitor 1B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConcarlo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesConcarlo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A